Semaglutide-glycine-cyanocobalamin recalls
The FDA has published 1 recall involving Semaglutide-glycine-cyanocobalamin since 2026. The latest was reported on 22 Apr 2026. Most were for sterility. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.
Total recalls1since 2026
Last 12 months1reported
Class I00% of total
Ongoing1latest 22 Apr 2026
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 1 100%Class III 0 0%
Why semaglutide-glycine-cyanocobalamin is recalled
Companies
By year
Ongoing semaglutide-glycine-cyanocobalamin recalls
1 active| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Semaglutide-Glycine-Cyanocobalamin Injectable, 2.5 mg, 5 mg recalled | Payless Compounders | Sterility | OR |
All semaglutide-glycine-cyanocobalamin recalls, newest first
1 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Semaglutide-Glycine-Cyanocobalamin Injectable, 2.5 mg, 5 mg recalled | Payless Compounders | Sterility | OR |
Should you stop taking Semaglutide-glycine-cyanocobalamin?
Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.